Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65626 - 65650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	SIRT1	23411	upregulated	resveratrol results in increased expression of SIRT1 mRNA	10q21.3	A23875 A24009 A24010 A23856 A23888 A23850 A23994
Resveratrol	Investigational	SIRT2	22933	downregulated	resveratrol results in decreased expression of SIRT2 mRNA	19q13.2	A24008
Resveratrol	Investigational	SIRT3	23410	downregulated	resveratrol results in decreased expression of SIRT3 mRNA	11p15.5	A24008
Resveratrol	Investigational	SIRT3	23410	upregulated	resveratrol results in increased expression of SIRT3 mRNA	11p15.5	A24011
Resveratrol	Investigational	SLC10A2	6555	downregulated	resveratrol results in decreased expression of SLC10A2 mRNA	13q33.1	A24012
Resveratrol	Investigational	SLC12A4	6560	upregulated	resveratrol results in increased expression of SLC12A4 mRNA	16q22.1	A23845
Resveratrol	Investigational	SLC15A1	6564	upregulated	resveratrol results in increased expression of SLC15A1 mRNA	13q32.2-q32.3	A22766
Resveratrol	Investigational	SLC1A5	6510	upregulated	resveratrol results in increased expression of SLC1A5 mRNA	19q13.32	A22289
Resveratrol	Investigational	SLC25A11	8402	upregulated	resveratrol results in increased expression of SLC25A11 mRNA	17p13.2	A21103
Resveratrol	Investigational	SLC2A2	6514	upregulated	resveratrol results in increased expression of SLC2A2 mRNA	3q26.2	A23945
Resveratrol	Investigational	SLC31A1	1317	upregulated	resveratrol results in increased expression of SLC31A1 mRNA	9q32	A22289
Resveratrol	Investigational	SLC41A3	54946	downregulated	resveratrol results in decreased expression of SLC41A3 mRNA	3q21.2-q21.3	A22289
Resveratrol	Investigational	SLC45A2	51151	downregulated	resveratrol results in decreased expression of SLC45A2 mRNA	5p13.2	A21739
Resveratrol	Investigational	SLC5A5	6528	upregulated	resveratrol results in increased expression of SLC5A5 mRNA	19p13.11	A22769 A23943
Resveratrol	Investigational	SLCO2A1	6578	upregulated	resveratrol results in increased expression of SLCO2A1 mRNA	3q22.1-q22.2	A22289
Resveratrol	Investigational	SMAD2	4087	downregulated	resveratrol results in decreased expression of SMAD2 mRNA	18q21.1	A23858 A24013
Resveratrol	Investigational	SMAD3	4088	downregulated	resveratrol results in decreased expression of SMAD3 mRNA	15q22.33	A24013
Resveratrol	Investigational	SMAD4	4089	downregulated	resveratrol results in decreased expression of SMAD4 mRNA	18q21.2	A23858 A24013 A24014
Resveratrol	Investigational	SMAD7	4092	upregulated	resveratrol results in increased expression of SMAD7 mRNA	18q21.1	A23858 A24013
Resveratrol	Investigational	SMC4	10051	downregulated	resveratrol results in decreased expression of SMC4 mRNA	3q25.33	A23857
Resveratrol	Investigational	SMC4	10051	upregulated	resveratrol results in increased expression of SMC4 mRNA	3q25.33	A21103
Resveratrol	Investigational	SMN2	6607	upregulated	resveratrol affects the splicing of and results in increased expression of SMN2 mRNA alternative form	5q13.2	A21856
Resveratrol	Investigational	SMO	6608	downregulated	resveratrol results in decreased expression of SMO mRNA	7q32.1	A22670
Resveratrol	Investigational	SNAI1	6615	downregulated	resveratrol results in decreased expression of SNAI1 mRNA	20q13.13	A23846
Resveratrol	Investigational	SNAI2	6591	downregulated	resveratrol results in decreased expression of SNAI2 mRNA	8q11.21	A23846 A23897

Displaying entries 65626 - 65650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability